NK-LGL LEUKEMIA
Clinical trials for NK-LGL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new NK-LGL LEUKEMIA trials appear
Sign up with your email to follow new studies for NK-LGL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancers: targeted drug trial opens
Disease control Recruiting nowThis study tests a drug called golidocitnib in people with slow-growing but hard-to-treat T/NK-cell lymphomas that have not responded to standard therapy. The goal is to see if the drug can shrink or control the cancer. About 48 adults will take the drug by mouth, and researchers…
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Old drug, new hope? thalidomide trial targets rare leukemia
Disease control Recruiting nowThis phase 2 trial tests thalidomide, a drug once used for other conditions, in 48 people with symptomatic large granular lymphocytic (LGL) leukemia. Participants start on thalidomide alone; if it doesn't work well enough, methotrexate is added. The goal is to see if thalidomide …
Matched conditions: NK-LGL LEUKEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Massive new registry to track thousands of blood cancer patients for years
Knowledge-focused Recruiting nowThis study is a registry that will follow up to 8,000 people with chronic lymphocytic leukemia (CLL) and related blood cancers over many years. It does not test a new treatment but instead collects information on how patients are doing over time, including survival. The goal is t…
Matched conditions: NK-LGL LEUKEMIA
Sponsor: German CLL Study Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC